GOLDEN-EURO
Champagnen flyder, og fejringen er godt undervejs i Golden Euro-casinoet, efter en heldig spiller ramte jackpotten og landede en monstergevinst på 3.746.291 €.
Spillerens gevinst blev udløst på Realtime Gamings enormt populære spillemaskine Aztec Millions og er den største gevinst nogensinde, der er blevet registreret på det progressive jackpotspil og hos Golden Euro.
Den 49-årige spiller foretog en indbetaling med kreditkort på 27 € for at starte sin session og for at få Golden Euros højtelskede 50 % indbetalingsmatchbonus, hvilket gave hende derfor 54 € at spille med.
Men selve gevinsten kom fra en lille indsats på blot 5 €, som hun foretog på sin smartphone - efterhånden som hjulene stoppede og jackpotten blev udløst, blev spilleren øjeblikkeligt millionær.
Adrian Berger fra Golden Euro Casino udtalte: "Vi er superglade for, at en af vores spillere landende den største jackpotgevinst nogensinde på Realtime Gamings Aztec Millions.
"Jeg talte med spilleren kort tid efter at have bekræftet hendes gevinst, og hun var i den syvende himmel, selvom det faktum, at hun nu er multimillionær, endnu ikke er gået helt op for hende.
"Disse gevinster er lige præcis, hvad Golden Euro handler om – vi vil gerne give vores spillere en sjov og underholdende online casinooplevelse med livsændrende gevinster, der kun er ét spin væk.
"Jeg vil endnu en gang lykønske vores heldige spiller, og jeg glæder mig til at annoncere flere store vindere og jackpotvindere hos Golden Euro i de kommende måneder."
Aztec Millions-jackpotten er atter på højkant og har allerede rundet over 1 million euro, så husk at prøve lykken og se, om du bliver den næste Golden Euro-millionær.
Jackpotværdien stiger hurtigt, fordi det er en progressiv netværksjackpot, hvilket betyder, at alle spillere, som spiller spillet på tværs af alle de casinoer, som tilbyder spillet, bidrager til jackpottens samlede sum.
Aztec Millions kan spilles på Golden Euro via download, øjeblikkeligt spil og i mobilens webbrowser.
Golden Euro Casino blev grundlagt i 2012 og er siden blevet en af de mest populære sider takket være sit fantastiske udvalg af spil, generøse bonusser og venlige kundesupport.
SLUT
Afsenders bemærkning:
Om Golden Euro Casino:
https://www.goldeneuro.com/en/
Se kildeudgaven på businesswire.com: https://www.businesswire.com/news/home/20210413005871/da/
Link:
Information om Business Wire
Følg pressemeddelelser fra Business Wire
Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.
Flere pressemeddelelser fra Business Wire
Merz Therapeutics to Present Broad Range of Clinical, Real-World and Mechanistic Data at TOXINS 20268.12.2025 08:00:00 CET | Press release
Merz Therapeutics to present more than 20 abstracts and posters at the TOXINS 2026 8th International Conference, taking place January 14-17 2026 in Madrid, Spain. Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that the company will present more than 20 clinical and non-clinical abstracts and posters spanning spasticity, movement disorders, and neurotoxin science at the TOXINS 2026 8th International Conference, taking place January 14–17, 2026, in Madrid, Spain. These presentations underscore the company’s commitment to addressing unmet needs in neurological disorders. “Our research reflects a relentless focus on improving patient outcomes through innovation in neurotoxin science,” said Dr. Stefan Albrecht, Chief Scientific and Medical Officer at Merz Therapeutics. “By presenting these new data at TOXINS 2026, we aim to foster scientific exchange and advance treatment strategies that address real-world challenges for patients and clinicians.”
Galderma Welcomes Increased Equity Investment From L’Oréal8.12.2025 07:05:00 CET | Press release
L’Oréal to acquire an additional 10% stake in Galderma recognizing its scientific leadership in dermatology and long-term growth potential Ad hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced that L’Oréal Groupe intends to increase its equity investment in the company, acquiring an additional 10% stake from Sunshine SwissCo GmbH (a consortium led by EQT, Abu Dhabi Investment Authority (ADIA), and Auba Investment Pte. Ltd., acting as sellers). Following the transaction, which is subject to customary approvals, L’Oréal’s total shareholding in Galderma will rise to 20%, building on its initial investment made in August 2024. The transaction is expected to close in Q1 2026. In connection with this increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal, replacing the board members representing the consortium led by EQT, at the 2026 Annual General Meeting. Additio
Ant International Wins Champion of NeurIPS Competition of Fairness in AI Face Detection8.12.2025 04:37:00 CET | Press release
The Challenge: Deepfakes undermine both the accuracy and fairness of AI face detection due to variations in human features.The Technology: Ant International’s AI model uses a novel ‘Mixture of Experts’-based Adversarial Debiasing approach to achieve superior fairness and accuracy across diverse demographics.The Impact: This advancement strengthens payment security, offering robust protection against deepfake fraud and enhancing eKYC compliance globally. Ant International, a leading global digital payment, digitisation, and financial technology provider, has won first place at the NeurIPS Competition of Fairness in AI Face Detection. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251207210856/en/ Ant International’s solution takes top spot at the NeurIPS Competition of Fairness in AI Face Detection, emerging first among over 2,100 submissions from 162 teams globally. AI Fairness enhances Financial Security Studies by the Nati
Sonrotoclax Data at ASH 2025 Confirm Foundational Potential Across B-cell Malignancies8.12.2025 00:00:00 CET | Press release
Novel BCL2 inhibitor sonrotoclax monotherapy demonstrates deep and durable clinical responses in R/R MCL and R/R CLLSonrotoclax in combination with BRUKINSA demonstrated rapid MRD negativity in treatment-naive CLL, regardless of high-risk features BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data on sonrotoclax, a next-generation investigational BCL2 inhibitor, demonstrating meaningful clinical benefit as monotherapy and in combination across B-cell malignancies. These data were featured at the 67th American Society of Hematology (ASH) Annual Meeting & Exposition in Orlando, Florida. The five presentations highlight durable responses in heavily pretreated patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL) and additional studies showing deep, rapid, and sustained undetectable minimal residual disease (uMRD) rates with sonrotoclax-based combinations in patients with treatment-naive chronic lymphocytic leukemi
Andersen Consulting tilføjer samarbejdsfirmaet Codezilla7.12.2025 21:19:00 CET | Pressemeddelelse
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem en samarbejdsaftale med Codezilla, et firma med hovedsæde i Rumænien, der udvikler specialtilpasset software. Codezilla specialiserer sig i at udvikle skræddersyede softwareprodukter, der løser forretningsmæssige udfordringer gennem en tværfaglig tilgang, som kombinerer softwareudvikling med dybdegående marketingekspertise. Med over 30 år på markedet fungerer firmaet som implementerings- og digital konsulentressource for reklamebureauer, samtidig med at de arbejder med en bred kundebase, herunder virksomheder inden for sundhedssektoren og medicinsk udstyr. Codezillas interne teams strækker sig over teknik, design og strategi og leverer omnichannel-løsninger til både regionale og globale kunder. "Vi tror på, at fantastisk software er resultatet af solid ingeniørkunst og disciplineret eksekvering," udtaler Sebastian Doroftei, administrerende direktør for Codezilla. "Vores samarbejde med Andersen Consulti
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.
Besøg vores nyhedsrum